As of 2024-12-14, the Relative Valuation of Surgical Science Sweden AB (SUS.ST) is 105.05 SEK. This relative valuation is based on P/E multiples. With the latest stock price at 153.40 SEK, the upside of Surgical Science Sweden AB based on Relative Valuation is -31.5%.
The range of the Relative Valuation is 84.35 - 131.70 SEK.
| Range | Selected | |
| Trailing P/E multiples | 22.3x - 25.7x | 24.5x |
| Forward P/E multiples | 26.9x - 30.7x | 27.3x |
| Fair Price | 84.35 - 131.70 | 105.05 |
| Upside | -45.0% - -14.1% | -31.5% |
| Date | P/E |
| 2024-12-12 | 39.82 |
| 2024-12-11 | 39.85 |
| 2024-12-10 | 39.82 |
| 2024-12-09 | 39.64 |
| 2024-12-06 | 39.75 |
| 2024-12-05 | 38.74 |
| 2024-12-04 | 39.53 |
| 2024-12-03 | 38.69 |
| 2024-12-02 | 39.46 |
| 2024-11-29 | 39.11 |
| 2024-11-28 | 39.30 |
| 2024-11-27 | 39.90 |
| 2024-11-26 | 38.77 |
| 2024-11-25 | 39.19 |
| 2024-11-22 | 38.56 |
| 2024-11-21 | 38.56 |
| 2024-11-20 | 37.48 |
| 2024-11-19 | 37.90 |
| 2024-11-18 | 37.61 |
| 2024-11-15 | 37.40 |
| 2024-11-14 | 36.55 |
| 2024-11-13 | 31.96 |
| 2024-11-12 | 30.88 |
| 2024-11-11 | 30.35 |
| 2024-11-08 | 31.96 |
| 2024-11-07 | 32.99 |
| 2024-11-06 | 32.25 |
| 2024-11-05 | 33.78 |
| 2024-11-04 | 33.91 |
| 2024-11-01 | 33.75 |
| 2024-10-31 | 33.15 |
| 2024-10-30 | 33.99 |
| 2024-10-29 | 34.18 |
| 2024-10-28 | 34.49 |
| 2024-10-25 | 33.12 |
| 2024-10-24 | 33.28 |
| 2024-10-23 | 32.65 |
| 2024-10-22 | 33.20 |
| 2024-10-21 | 33.25 |
| 2024-10-18 | 34.20 |
| 2024-10-17 | 32.99 |
| 2024-10-16 | 33.33 |
| 2024-10-15 | 33.07 |
| 2024-10-14 | 33.49 |
| 2024-10-11 | 31.19 |
| 2024-10-10 | 30.90 |
| 2024-10-09 | 31.43 |
| 2024-10-08 | 31.85 |
| 2024-10-07 | 32.04 |
| 2024-10-04 | 31.67 |